Oxford Health Policy Forum

What Oxford Health Policy Forum does

Oxford Health Policy Forum is a not-for-profit community interest company (CIC) registered in England and Wales, established in 2016 and headquartered in Oxford, UK. The organization convenes multidisciplinary expert forums — comprising clinicians, economists, pharmacists, ethicists, nurses, patients, and policymakers — to produce evidence-based consensus policy reports on life-changing health conditions, with current therapeutic coverage spanning multiple sclerosis (MS), NMOSD, MOGAD, schizophrenia, neurodegenerative brain diseases, and heart failure.

The forum's core products are published reports and follow-on initiative campaigns, most prominently the MS Brain Health initiative (endorsed by 50+ organizations with 450+ champions across 65+ countries), Think Brain Health Global (a dementia risk reduction program), and the annual MS Brain Health Awards established in 2022. Each report is developed through expert steering committees, disseminated in multiple languages through dedicated websites and international congresses, and supported by an omnichannel strategy including video, infographics, and social media. The organization does not operate a technology platform; its product is intellectual content and policy convening.

The business model is a non-profit, project-funded model. The forum receives financial support from named pharmaceutical sponsors (Roche, Lundbeck, Boehringer Ingelheim, Horizon/Amgen) and patient organizations (Multiple Sclerosis Society) for specific report initiatives, and operates under strategic partnerships with bodies such as the Heart Failure Association of the European Society of Cardiology and the Academy of Medical Royal Colleges. All reports are freely available for download. No revenue figures, pricing, or valuation are publicly disclosed, and the organization employs 1-10 people.

Name

Oxford Health Policy Forum

Legal name

Oxford Health Policy Forum CIC

Website

https://www.oxfordhealthpolicyforum.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Oxford Health Policy Forum is a UK not-for-profit community interest company that convenes multidisciplinary expert forums to publish evidence-based consensus policy reports on neurological, mental health, and cardiovascular conditions, serving clinicians, policymakers, patients, and advocacy groups globally.

Ownership category

akta.pro rank

Product category

Health Policy Research

NAICS

Social Advocacy Organizations (8133), Voluntary Health Organizations (813212)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Public Health Strategy, Policy & Legislation (HLAJAMAA), Global Health Advocacy, Policy & Rights Organizations (HLAJAKAO), Health Systems Strengthening & Universal Health Coverage (UHC) (BPADAIAE)

Keywords

• Health policy reports
• Evidence-based policy
• Medical consensus forums
• Disease policy initiatives
• Healthcare advocacy

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Not-for-profit operations: Oxford Health Policy Forum CIC is a not-for-profit community interest company. The organization receives support from pharmaceutical companies and healthcare organizations for its initiatives and report production. As a not-for-profit, any surplus is reinvested into the organization's mission to drive policy change for life-changing conditions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Oxford Health Policy Forum produces evidence-based consensus policy reports and follow-on initiatives that drive change in healthcare policy for life-changing conditions, including multiple sclerosis, schizophrenia, brain diseases, and heart failure. It convenes multidisciplinary expert forums (clinicians, economists, ethicists, nurses, patients, policymakers) and runs branded initiatives such as MS Brain Health, Think Brain Health Global, and the MS Brain Health Awards.

Product overview

Oxford Health Policy Forum is a not-for-profit community interest company that publishes evidence-based policy reports and runs international initiative campaigns focused on health policy change. The organization operates multiple programs: its core products are policy reports on neurological conditions (multiple sclerosis, schizophrenia, brain diseases, heart failure) and related initiatives including the MS Brain Health Awards. Reports are developed through expert forums and stakeholder collaboration, with recommendations disseminated through omnichannel strategies. The organization also maintains supporting resources including video galleries, infographics, translations, and endorser networks spanning over 50 organizations globally.

Differentiator

Problem solved

Functional benefit

Brands

• MS Brain Health: An initiative focused on driving adoption of therapeutic strategies to maximize lifelong brain health of people with multiple sclerosis through policy recommendations and resources.
• Think Brain Health Global

Products and services

• Brain Health: Time Matters in Multiple Sclerosis Evidence-based consensus report presenting recommendations on diagnosis, therapeutic strategies and improving access to treatment in multiple sclerosis. The core recommendation is that the goal of treating MS should be to preserve tissue in the central nervous system and maximize lifelong brain health by reducing disease activity.
• Brain health – time matters 2024: MS, NMOSD, MOGAD and related conditions Updated 2024 report expanding the original 2015 publication to include NMOSD (neuromyelitis optica spectrum disorder) and MOGAD (myelin oligodendrocyte glycoprotein antibody disease). Emphasizes timely diagnosis and treatment initiation, holistic person-centred care, and consultation of robust emerging evidence.
• Schizophrenia: Time to Commit to Policy Change 2024 Policy report exploring the unique needs of people with schizophrenia, providing practical and attainable recommendations for change. Emphasizes multifaceted approach including policy development, treatment guidance and scientific innovation.
• Schizophrenia: Time to Commit to Policy Change (2014) Original policy report from 2014 developed by an international group of patients, carers and experts in schizophrenia calling for a more comprehensive, recovery-based approach towards management and care.
• Time Matters: A Call To Prioritize Brain Health Policy report addressing neurodegenerative diseases such as Alzheimer's and Parkinson's. Presents expert evidence-based recommendations challenging policymakers, researchers, funding bodies and healthcare professionals to collaborate in planning for future healthcare structures.
• Heart Failure: Preventing Disease and Death Worldwide White paper produced in collaboration with experts from six continents addressing the health and economic crisis imposed by heart failure. Evidence-based policy recommendations with potential to drive improvements to save lives.
• Acute Heart Failure: Improving Care For Patients With Acute Heart Failure Policy initiative aimed at improving care for patients with acute heart failure through clear policy initiatives and rational redesign of patient management pathways and healthcare provision.
• Doctor, who? The Changing Face of Medicine Report exploring the future of medicine and healthcare roles, developed under the auspices of the Academy of Medical Royal Colleges. Identifies five key themes for future healthcare system development.
• MS Brain Health Awards International awards program established to recognize and showcase excellence in championing the importance of brain health and timely intervention in managing multiple sclerosis. Covers categories including Patient Organization, Patient Advocate, Team, Individual and Innovation.
• MS Brain Health Initiative Campaign initiative to drive adoption of therapeutic strategy to maximize lifelong brain health of people with MS. Has endorsement from more than 50 organizations representing MS neurologists, nurses, health economists and patients, and 450 champions from more than 65 countries.
• Think Brain Health Global Global initiative focused on brain health awareness and dementia risk reduction. Provides resources and policy recommendations for prioritizing brain health across populations.

Quantifiable outcome

• Lifestyle recommendations incorporated into newly updated standards for diagnosis and treatment
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Heart Failure Association of the European Society of CardiologycoreStrategic or Co-development PartnerEndorsed and adopted recommendations from both the Heart Failure white paper and Acute Heart Failure reports as part of the HFA-ESC Global Heart Failure Awareness Programme. This represents a core partnership for influencing European and global heart failure policy.
• Academy of Medical Royal CollegescoreStrategic or Co-development PartnerThe Changing Face of Medicine project operates under the auspices of the Academy of Medical Royal Colleges. This commission develops visions for the future of medicine and healthcare, with Oxford Health Policy Forum supporting conference development and strategic communication.
• 50+ International MS Organizations (Endorsers)coreStrategic or Co-development PartnerOver 50 organizations including Accelerated Cure Project for MS, American Association of Neuroscience Nurses, ECTRIMS, European Multiple Sclerosis Platform, MS Society UK, National MS Society, MS Australia, MS Canada, and others have endorsed the Brain health – time matters 2024 report, representing MS neurologists, nurses, health economists and patients globally.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Health Policy Partnership: London-based health policy consultancy that develops policy reports and engages stakeholders to drive change in disease areas including cardiovascular and neurological conditions. Closest direct analog to OHPF's forum-based, pharma-funded evidence-to-policy model.
• European Brain Council: Brussels-based not-for-profit that produces evidence-based policy positions and convenes researchers, clinicians, patients, and industry on neurological and mental health conditions. Directly comparable in mission and stakeholder model to OHPF's neurology work.
• International Alliance of Patients' Organizations (IAPO): Global alliance of patient organizations that influences health policy through evidence-based advocacy and multi-stakeholder engagement. Comparable convener model targeting policy change for life-changing conditions.
• European Patients' Academy on Therapeutic Innovation (EUPATI): Pan-European initiative providing education and policy advocacy on patient involvement in health research and treatment access. Comparable mission of patient-centered health policy enablement through multi-stakeholder engagement.
• European Multiple Sclerosis Platform (EMSP): Pan-European umbrella organization for MS societies that influences policy on MS care and research. Comparable as one of OHPF's endorsing organizations in the MS Brain Health initiative and an adjacent stakeholder in MS policy.

Broad incumbents

• Nuffield Trust: UK-based independent health policy think tank producing evidence-based research on health and social care systems. Comparable as a UK-headquartered evidence-to-policy organization, though focused on health systems rather than specific diseases.
• The King's Fund: Independent English health think tank working on health policy, leadership, and care system improvement. Comparable as a UK-based evidence-driven health policy organization, though with broader health-system focus.
• Wellcome Trust: Major charitable foundation funding global health research and policy initiatives on multiple conditions. Comparable as a not-for-profit organization influencing health policy across neurological, mental health, and infectious disease areas.
• RAND Corporation Health Division: Global policy research organization with a dedicated health division producing evidence-based research on healthcare delivery and policy. Comparable as evidence-based health policy producer, though with much broader scope and scale.
• Health Foundation: UK-based independent charity working to improve health and health care through evidence-based policy analysis. Comparable as a UK-headquartered health policy research and advocacy organization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/oxhealthpolicy
• LinkedInlinkedin.com/company/oxford-health-policy-forum

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford Health Policy Forum